Addressing Disparities in Oncology Patient Care: Awareness, Education, and Action!
September 29, 2023
March 29, 2024
This activity is jointly provided by Postgraduate Healthcare Education, LLC (PHE) and Postgraduate Institute for Medicine (PIM).
This activity is supported by an independent educational grant from Bristol Myers Squibb.
- Pharmacist — 0.5 hour (0.05 ceu)[PHARMACISTS: PLEASE GO TO POWERPAK at https://www.powerpak.com/course/preamble/124162 TO COMPLETE THIS LESSON AND CLAIM CREDIT.]
- Nurses — 0.5 Contact Hour
All other healthcare professionals completing this course will be issued a statement of participation.
Oncology Pharmacists, Nurses and Nurse Practitioners
To provide oncology pharmacists and oncology nurses with information, insights, and solutions that can be applied at both systems and local levels to identify, address, and rectify inequities in oncology healthcare delivery related to race or culture, sex or gender identity, sexual preference, and other issues.
Upon completion of this activity, participants should be better able to:
- Identify disparities in oncology care delivery in order to implement corrective strategies
- Discuss steps for improving health care delivery among patient groups affected by inequalities, stigma, and bias or perceptions of bias and effective methods to do so
Onyebuchi Ononogbu, PharmD, BCOP
Department of Pharmacy Practice and Translational Research
University of Houston
Hematology/Oncology Clinical Pharmacy Specialist
UT Physicians Comprehensive Sickle Cell Center
Faith Mutale, CRNP, DNP
Adjunct Faculty/Clinical Associate
University of Pennsylvania School of Nursing
Hematology/Oncology Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credits: 0.5 hour (0.05 ceu)
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hour.
How to Earn Credit: Pharmacists
Participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the posttest and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
There is no fee for this educational activity.
Dr. Ononogbu has disclosed that she has no relevant affiliations or financial relationships with a commercial interest to disclose.
Dr. Mutale has disclosed that she has received honoraria for non-CME activities from Helsinn Therapeutics, Inc, and Merck & Co.; and consultant fees from Pfizer.
The clinical reviewer, Megan May, PharmD, BCOP, has disclosed that she has no relevant affiliations or financial relationships with a commercial interest to disclose.
Susanne Batesko, MSHF, BSN, RN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.
The PIM planners and others have nothing to disclose.
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
All relevant financial relationships have been mitigated.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC, Postgraduate Institute for Medicine (PIM), or Bristol Myers Squibb. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA.